EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

Avanex Corporation Announces Fiscal 2009 Second

Quarter Financial Results

FREMONT, Calif., February 5, 2009 — Avanex Corporation (NASDAQ: AVNX), a pioneer of intelligent photonic solutions that enable next-generation optical networks, today reported its fiscal 2009 second quarter financial results for the quarter ended December 31, 2008.

Net revenue in the second quarter of fiscal 2009 was $38.0 million, a decrease of 16.1 percent from $45.3 million in the first quarter of fiscal 2009, and a decrease of 26.9 percent from $52.0 million in the same period last year.

Gross margin in the second quarter of fiscal 2009 was 15.4%, a decrease from 17.2% in the first quarter of fiscal 2009, and a decrease from 31.0% in the same period last year.

Net loss in the second quarter of fiscal 2009 was $16.8 million, or ($1.08) per diluted share, compared with net loss of $9.6 million, or ($0.63) per diluted share in the first quarter of fiscal 2009. This compares to net income of $86,000, or $0.01 per diluted share in the same period last year. During the second quarter of fiscal 2009, the company wrote-off $9.6 million relating to goodwill and intangibles.

Non-GAAP net loss in the second quarter of fiscal 2009 was $6.2 million, or ($0.40) per diluted share, compared with net loss of $5.9 million, or ($0.38) per diluted share, in the first quarter of fiscal 2009. This compares to non-GAAP net income of $2.4 million, or $0.15 per diluted share in the same period last year.*

“While the company is continuing to face challenges in light of the current macro-economic environment, we are taking action by reducing our workforce by 5% and scaling back on other discretionary expenses. We believe that the proposed merger with Bookham, Inc. announced last week will improve our market position,” said Giovanni Barbarossa, CEO and President of Avanex.

Q3 FY 2009 Outlook

The company expects revenue to be between $24 million and $31 million in the third quarter of fiscal 2009, ending March 31, 2009. Given the current recessionary macro economic environment, there is less visibility than typical, and accordingly the company’s guidance range is broader than normal.

Investor Conference Call

Avanex will host a conference call to discuss fiscal 2009 second quarter results at 1:30 p.m. PST today. Investors are invited to listen to a live broadcast of the conference call via webcast, which can be accessed by visiting the Avanex Investor Relations website at http://investor.avanex.com/events.cfm. Investors can also listen to the conference call by dialing 913-312-1298.


A replay of the call will be available through an archived webcast at http://investor.avanex.com/events.cfm. An audio replay will be available through 12 AM eastern daylight time on February 12, 2009 and can be accessed by dialing 888-203-1112 (domestic) or 719-457-0820 (international) and entering access ID number 3498701.

Future Investor Conference

Avanex will be presenting at The Thomas Weisel Partners Technology and Telecom Conference on Wednesday, February 11, 2009 at 9:10 a.m. Pacific Time. The conference will be held at the Fairmount Hotel in San Francisco. The live webcast will be available via a link on the Investor Relations page of the Avanex web site at www.avanex.com. A replay of the webcast will be available for 30 days following the live presentation.

About Avanex

Avanex Corporation is a leading global provider of Intelligent Photonic Solutions(TM) to meet the needs of fiber optic communications networks for greater capacity, longer distance transmissions, improved connectivity, higher speeds and lower costs. These solutions enable or enhance optical wavelength multiplexing, dispersion compensation, switching and routing, transmission, amplification, and include network-managed subsystems. Avanex Corporation was incorporated in 1997 and is headquartered in Fremont, California. Avanex Corporation also maintains facilities in Horseheads, New York; Shanghai, China; Villebon Sur Yvette, France; San Donato, Italy; and Bangkok, Thailand. To learn more about Avanex Corporation, visit our web site at: www.avanex.com.

Forward-looking Statements

This press release contains forward-looking statements including statements regarding expected third quarter of fiscal 2009 outlook and future operating results, the benefits of the business combination transaction involving Bookham and Avanex, competitive and market position and our strategies. Actual results could differ materially from those projected in or contemplated by the forward-looking statements. Factors that could cause actual results to differ include general economic conditions, the pace of spending in the telecommunications industry and in particular the optical networks industry, market demand and price of our products, the company’s ability to sufficiently anticipate market needs and develop products and enhancements that achieve market acceptance, unanticipated costs and expenses or the inability to identify expenses which can be eliminated, any slowdown or deferral of orders for products or the application of accounting or tax principles in an unanticipated manner, risks relating to the consummation of the contemplated merger, including the risk that required stockholder approval might not be obtained in a timely manner or at all or that


other closing conditions are not satisfied, the failure to realize synergies and cost-savings from the transaction or delay in realization thereof, the businesses or employees of Bookham and Avanex not be combined and integrated successfully, or such combination may take longer, be more difficult, time-consuming or costly to accomplish than expected, and operating costs and business disruption following the merger, including adverse effects on employee retention and on our business relationships with third parties.

Finally, please refer to the risk factors contained in the company’s SEC filings including the company’s Annual Report on Form 10-K filed with the SEC on Sept. 5, 2008 and subsequent filings with the SEC.

Avanex assumes no obligation and does not intend to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

This communication is being made in respect of the proposed business combination involving Bookham and Avanex. In connection with the proposed transaction, Bookham and Avanex plan to file documents with the SEC, including the filing by Bookham of a Registration Statement on Form S-4 containing a Joint Proxy Statement/Prospectus and each of Bookham and Avanex plan to file with the SEC other documents regarding the proposed transaction. Investors and security holders of Bookham and Avanex are urged to carefully read the Joint Proxy Statement/Prospectus (when available) and other documents filed with the SEC by Bookham and Avanex because they will contain important information about the proposed transaction. Investors and security holders may obtain free copies of these documents (when they are available) and other documents filed with the SEC at the SEC’s web site at www.sec.gov and by contacting Bookham Investor Relations at (408) 404-5400 or Avanex Investor Relations at (510) 897-4188. Investors and security holders may obtain free copies of the documents filed with the SEC on Bookham’s website at www.bookham.com or Avanex’s website at www.avanex.com or the SEC’s website at www.sec.gov. Bookham, Avanex and their respective directors and executive officers may be deemed participants in the solicitation of proxies with respect to the proposed transaction. Information regarding the interests of these directors and executive officers in the proposed transaction will be included in the Joint Proxy Statement/Prospectus described above. Additional information regarding the directors and executive officers of Bookham is also included in Bookham’s proxy statement for its 2008 Annual Meeting of Stockholders, which was filed with the SEC on September 18, 2008, and additional information regarding the directors and executive officers of Avanex is also included in Avanex’s proxy statement for its 2008 Annual Meeting of Stockholders, which was filed with the SEC on October 14, 2008, respectively.


* Non-GAAP net income (loss) and non-GAAP net income (loss) per share exclude share-based compensation expenses, amortization of intangibles, impairment of goodwill and intangibles, restructuring charges, due diligence expenses related to abandoned acquisition activity, and arbitration expenses. Details on the items excluded from non-GAAP net income (loss) and non-GAAP net income (loss) per share are available in the table entitled, “Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income (Loss),” following the accompanying financial statements.

Contact Information:

Investor Relations

Mark Weinswig

510 897-4188

IR@Avanex.com


Avanex Corporation

CONSOLIDATED BALANCE SHEET

In thousands

(Unaudited)

 

     December 31,
2008
    September 30,
2008
    June 30,
2008
 

Assets

      

Current assets:

      

Cash and cash equivalents

   $ 13,897     $ 13,712     $ 14,839  

Restricted cash

     3,803       3,792       3,776  

Short-term investments

     19,550       32,162       40,590  

Accounts receivable, net

     30,197       34,068       39,032  

Inventories

     19,528       19,281       15,979  

Due from related party

     123       141       85  

Other current assets

     7,021       7,276       6,486  
                        

Total current assets

     94,119       110,432       120,787  

Property and equipment, net

     8,906       8,994       7,688  

Intangibles, net

     —         260       314  

Goodwill

     —         9,408       9,408  

Other assets

     3,094       3,325       2,870  
                        

Total assets

   $ 106,119     $ 132,419     $ 141,067  
                        

Liabilities and Stockholders’ Equity

      

Current liabilities:

      

Accounts payable

   $ 24,371     $ 33,673     $ 33,255  

Accrued compensation

     3,811       3,887       6,272  

Accrued warranty

     350       476       626  

Other accrued expenses and deferred revenue

     6,885       6,110       6,003  

Current portion of long-term obligations

     12       12       13  

Current portion of accrued restructuring

     3,068       4,809       2,940  
                        

Total current liabilities

     38,497       48,967       49,109  

Long-term liabilities:

      

Accrued restructuring

     3,613       4,260       5,043  

Other long-term obligations

     1,364       1,411       1,520  
                        

Total liabilities

     43,474       54,638       55,672  
                        

Contingencies

      

Stockholders’ equity:

      

Common stock

     16       16       15  

Additional paid-in capital

     788,204       786,721       784,492  

Accumulated other comprehensive income

     1,269       1,074       1,277  

Accumulated deficit

     (726,844 )     (710,030 )     (700,389 )
                        

Total stockholders’ equity

     62,645       77,781       85,395  
                        

Total liabilities and stockholders’ equity

   $ 106,119     $ 132,419     $ 141,067  
                        


Avanex Corporation

CONSOLIDATED STATEMENTS OF OPERATIONS - GAAP

In thousands, except for per share data

(Unaudited)

 

     Three Months Ended  
     December 31,
2008
    September 30,
2008
    December 31,
2007
 

Net revenue:

      

Third parties

   $ 37,924     $ 45,213     $ 47,155  

Related parties

     77       61       4,852  
                        

Total net revenue

     38,001       45,274       52,007  

Cost of revenue:

      

Cost of revenue except for purchases from related parties

     31,864       37,040       35,567  

Purchases from related parties

     295       461       321  
                        

Total cost of revenue

     32,159       37,501       35,888  
                        

Gross profit

     5,842       7,773       16,119  

Operating expenses:

      

Research and development

     6,037       6,685       7,604  

Sales and marketing

     2,827       4,052       4,202  

General and administrative

     3,777       4,888       4,980  

Amortization of intangibles

     53       54       101  

Restructuring

     157       2,319       2  

Impairment of goodwill and intangibles

     9,615       —         —    
                        

Total operating expenses

     22,466       17,998       16,889  
                        

Loss from operations

     (16,624 )     (10,225 )     (770 )

Interest and other income (expense), net

     (179 )     (172 )     1,083  
                        

Income (loss) before income taxes

     (16,803 )     (10,397 )     313  

Income tax benefit (provision)

     (11 )     756       (227 )
                        

Net income (loss)

   $ (16,814 )   $ (9,641 )   $ 86  
                        

Basic net income (loss) per common share

   $ (1.08 )   $ (0.63 )   $ 0.01  
                        

Diluted net income (loss) per common share

   $ (1.08 )   $ (0.63 )   $ 0.01  
                        

Weighted-average number of shares used in computing:

      

Basic net income (loss) per common share

     15,564       15,355       15,235  
                        

Diluted net income (loss) per common share

     15,564       15,355       15,460  
                        


Avanex Corporation

RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME (LOSS)

In thousands, except for per share data

(Unaudited)

 

     Three Months Ended
     December 31,
2008
    September 30,
2008
    December 31,
2007

Net income (loss), GAAP

   $ (16,814 )   $ (9,641 )   $ 86

Items reconciling GAAP net income (loss) to non-GAAP net income (loss):

      

Related to cost of revenue:

      

Share-based payments

     261       284       319

(Gain) from legal settlement

     —         —         —  
                      

Total related to cost of sales

     261       284       319
                      

Related to operating expenses:

      

Research and development - share-based payments

     241       326       698

Sales and marketing - share-based payments

     296       527       208

General and administrative - share-based payments

     (28 )     263       561

Amortization of intangibles

     53       54       101

Restructuring

     157       2,319       2

Impairment of goodwill and intangibles

     9,615       —         —  

Due diligence expenses related to abandoned acquisition activity

     —         —         199

Arbitration expenses

     —           185
                      

Total related to operating expenses

     10,334       3,489       1,954
                      

Total related to net income (loss)

     10,595       3,773       2,273
                      

Non-GAAP net income (loss)

   $ (6,219 )   $ (5,868 )   $ 2,359
                      

Basic non-GAAP net income (loss) per common share

   $ (0.40 )   $ (0.38 )   $ 0.15
                      

Diluted non-GAAP net income (loss) per common share

   $ (0.40 )   $ (0.38 )   $ 0.15
                      

Weighted-average number of shares used in computing:

      

Basic non-GAAP net income (loss) per common share

     15,564       15,355       15,235
                      

Diluted non-GAAP net income (loss) per common share

     15,564       15,355       15,460